WARREN, N.J., April 03, 2024 Tevogen Bio Holdings Inc , a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development..
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Tevogen Bio Announces Series A-1 Preferred Stock Investment tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.